✦ LIBER ✦

A comparison of the efficacy and tolerability of titrate-to-goal regimens of simvastatin and fluvastatin: a randomized, double-blind study in adult patients at moderate to high risk for cardiovascular disease

✍ Scribed by Marjel J van Dam; Huub J.A.M Penn; Frank R den Hartog; Hans A Kragten; Mieke D Trip; Rudolf J.A Buirma; John J.P Kastelein

Book ID: 117321106
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 733 KB
Volume: 23
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(01)80050-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged ≥65 years with mild to moderate hypertension

✍ Yves Lacourcière 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 798 KB

Efficacy and tolerability of a generic a

Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: A multicenter, prospective, randomized, double-blind, double-dummy clinical trial

✍ Sang-Hyun Kim; Kyungil Park; Soon-Joon Hong; Young-Seok Cho; Ji-Dong Sung; Geon- 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 122 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

Mo2083 A Randomized, Double-Blind, Place

Mo2083 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease

✍ Stephan R. Targan; Brian G. Feagan; Severine Vermeire; Remo Panaccione; Gil Y. M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONT

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE

✍ Cummings, Jeffrey; Cho, William; Ward, Michael; Friesenhahn, Michel; Brunstein, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Comparison of the efficacy and tolerabil

Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild-to-moderate hypertension: a multicentre, double-blind study in Taiwanese patients

✍ J-H. Chen; J-J. Cheng; C-Y. Chen; H-C. Chiou; T-Y. Huang; C-D. Tsai; M.M-Y. Fu; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB